These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8862506)

  • 1. A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.
    Pinto AC; Czepielewski MA; Gross JL; Mussio W; Lengyel AM
    J Endocrinol Invest; 1996 Apr; 19(4):248-52. PubMed ID: 8862506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klinefelter's syndrome: examination of thyroid function, and the TSH and PRL responses to thyrotropin-releasing hormone prior to and after testosterone administration.
    Burman KD; Dimond RC; Noel GL; Earll JM; Frantz AG; Wartofsky L
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1161-6. PubMed ID: 812883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease associated with Klinefelter's syndrome.
    Park JS; Kim CS; Nam JY; Kim DM; Yoon SJ; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Yonsei Med J; 2004 Apr; 45(2):341-4. PubMed ID: 15119010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three patients with gynaecomastia].
    Walraven M; Wilmink HJ; de Boer LM; Muller AF
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):809-13. PubMed ID: 15141644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prolactin secretion and thyrotrophin response to thyrotrophin releasing hormone in Klinefelter's syndrome.
    Kumanov P
    Andrologia; 1995; 27(1):41-5. PubMed ID: 7755189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
    Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
    Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
    Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
    Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.
    Bojesen A; Høst C; Gravholt CH
    Mol Hum Reprod; 2010 Jun; 16(6):396-401. PubMed ID: 20231162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome.
    Kübler A; Schulz G; Cordes U; Beyer J; Krause U
    Exp Clin Endocrinol; 1992; 100(3):129-32. PubMed ID: 1305064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Klinefelter's syndrome: diagnosis and treatment. Case report].
    Martini R
    Minerva Med; 2001 Oct; 92(5):385-92. PubMed ID: 11675582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tremor in Klinefelter's syndrome improved by testosterone administration.
    Kinoshita H; Ohkubo T; Kaneko M; Satoh N; Mizutani S; Yasuda M; Machida A; Ishikawa K; Kamata T; Yakushiji F
    J Neurol; 2009 Nov; 256(11):1924-5. PubMed ID: 19597693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leg ulcer in Klinefelter's syndrome.
    Igawa K; Nishioka K
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):62-4. PubMed ID: 12602973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis, evaluation and treatment of hypogonadism in men].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2009; 60(3):222-33. PubMed ID: 19569024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.
    Wong FH; Pun KK; Wang C
    Osteoporos Int; 1993 Jan; 3(1):3-7. PubMed ID: 8422513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter's syndrome.
    Hussain A; Swaminathan R; Sankaralingam A; Carroll PV; Hampson G; McGowan BM
    Ital J Anat Embryol; 2013; 118(1 Suppl):34-6. PubMed ID: 24640568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy in Klinefelter's syndrome (a prolonged observation).
    Ruvalcaba RH
    Andrologia; 1989; 21(6):535-41. PubMed ID: 2619099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EEG of Klinefelter's syndrome with psychiatric disorders, and the effect of testosterone treatment].
    Takei H
    Seishin Shinkeigaku Zasshi; 1970 Oct; 72(10):983-1021. PubMed ID: 5531658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.